Cost effective on-demand medical isotope production
Astral System's multi-state fusion technology allows governments to decentralize medical isotope production into smaller distributed facilities ensuring nuclear medical independence.
We empower afforable access to critical care
Nuclear medicine is a vital tool used around the world to diagnose and treat life-threatening diseases every day.
Due to unreliable supply chains that rely on ageing fission reactors in Europe and abroad, many clinicians in the UK and elsewhere are unable to access the radioisotopes needed to deliver this critical care.
We aim to provide medical isotope production at the point of care for both diagnostic and therapeutic applications.
The Best Possible Access to Cancer Diagnostics and Treatment
Today's models of isotope production require the transport of these critical medicines to end-users throughout countries and across borders. This transport process can cause up to 87.5% of activity lost through radioactive decay before even reaching a radiopharmacy. Astral's compact technology can be deployed to decentralize medical isotope production into smaller distributed facilities ensuring a more resilient supply chain.
Increase supply chain resilience
Enabling domestic supply to reduce reliance on global supply chains vulnerable to crises or system shocks.
Faster time to patient, less decay
Reducing the time spent between the production source and patient, thus reducing isotope wastage due to decay.
.svg){kind=icon}
Isotope Agnostic
In the near future, we are looking to demonstrate, and then scale, production of Iodine-131, Lutetium-177, and later Actinium-225 amongst others.
Better research access
Increasing access for nuclear medicine researchers and clinicians to explore more effective procedures and applications.
Enable domestic supply and reduce dependencies
Most neutron-produced medical isotopes are generated at a small handful of ageing fission reactors around the world, of which a number will be decommissioned by 2030, resulting in 64% of global medical isotope production going offline. There are only a couple of new reactors being developed and they will not be able to replace the lost production capacity. Astral enables domestic supply of medical isotopes to reduce reliance on global supply chains.
Unlock the power of multi-state fusion
Contact us to learn how you can work with us and get access to our reliable and high-performance compact fusion reactors and isotope production for your organisation.
